Free Trial
NYSE:BHC

Bausch Health Cos (BHC) Stock Price, News & Analysis

Bausch Health Cos logo
$5.77 +0.01 (+0.17%)
Closing price 08/8/2025 03:59 PM Eastern
Extended Trading
$5.78 +0.01 (+0.17%)
As of 08/8/2025 06:27 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Bausch Health Cos Stock (NYSE:BHC)

Key Stats

Today's Range
$5.75
$5.81
50-Day Range
$4.49
$7.11
52-Week Range
$4.25
$9.85
Volume
843,013 shs
Average Volume
1.45 million shs
Market Capitalization
$2.14 billion
P/E Ratio
22.19
Dividend Yield
N/A
Price Target
$9.00
Consensus Rating
Hold

Company Overview

Bausch Health Cos Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
93rd Percentile Overall Score

BHC MarketRank™: 

Bausch Health Cos scored higher than 93% of companies evaluated by MarketBeat, and ranked 85th out of 923 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Bausch Health Cos has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 3 hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Bausch Health Cos has received no research coverage in the past 90 days.

  • Read more about Bausch Health Cos' stock forecast and price target.
  • Earnings Growth

    Earnings for Bausch Health Cos are expected to grow by 5.67% in the coming year, from $4.41 to $4.66 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Bausch Health Cos is 22.19, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 27.88.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Bausch Health Cos is 22.19, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 29.76.

  • Price to Book Value per Share Ratio

    Bausch Health Cos has a P/B Ratio of 14.43. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    2.56% of the float of Bausch Health Cos has been sold short.
  • Short Interest Ratio / Days to Cover

    Bausch Health Cos has a short interest ratio ("days to cover") of 3.7, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Bausch Health Cos has recently decreased by 10.58%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Bausch Health Cos does not currently pay a dividend.

  • Dividend Growth

    Bausch Health Cos does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    2.56% of the float of Bausch Health Cos has been sold short.
  • Short Interest Ratio / Days to Cover

    Bausch Health Cos has a short interest ratio ("days to cover") of 3.7, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Bausch Health Cos has recently decreased by 10.58%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    Bausch Health Cos has a news sentiment score of 0.55. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.38 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 4 news articles for Bausch Health Cos this week, compared to 4 articles on an average week.
  • Search Interest

    Only 22 people have searched for BHC on MarketBeat in the last 30 days. This is a decrease of -12% compared to the previous 30 days.
  • MarketBeat Follows

    Only 1 people have added Bausch Health Cos to their MarketBeat watchlist in the last 30 days. This is a decrease of -75% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Bausch Health Cos insiders have bought more of their company's stock than they have sold. Specifically, they have bought $35,870,767.00 in company stock and sold $0.00 in company stock.

  • Percentage Held by Insiders

    Only 8.05% of the stock of Bausch Health Cos is held by insiders.

  • Percentage Held by Institutions

    78.65% of the stock of Bausch Health Cos is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Bausch Health Cos' insider trading history.
Receive BHC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Bausch Health Cos and its competitors with MarketBeat's FREE daily newsletter.

BHC Stock News Headlines

Musk’s Project Colossus could mint millionaires
I predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new millionaires than any tech advance in history. And for a limited time, you have the chance to claim a stake in this project, even though it’s housed inside Elon’s private company, xAI.
See More Headlines

BHC Stock Analysis - Frequently Asked Questions

Bausch Health Cos' stock was trading at $8.06 at the beginning of 2025. Since then, BHC stock has decreased by 28.4% and is now trading at $5.77.

Bausch Health Cos Inc. (NYSE:BHC) posted its earnings results on Wednesday, July, 30th. The company reported $0.90 EPS for the quarter, missing the consensus estimate of $0.97 by $0.07. The firm earned $2.57 billion during the quarter, compared to analysts' expectations of $2.47 billion. Bausch Health Cos had a net margin of 0.99% and a negative trailing twelve-month return on equity of 852.36%.
Read the conference call transcript
.

Top institutional shareholders of Bausch Health Cos include SG Americas Securities LLC (1.66%), MUFG Securities EMEA plc (0.92%), TD Asset Management Inc (0.24%) and Bank of Montreal Can (0.24%). Insiders that own company stock include John Paulson and Seana Carson.
View institutional ownership trends
.

Shares of BHC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Bausch Health Cos investors own include Meta Platforms (META), NVIDIA (NVDA), Advanced Micro Devices (AMD), Alibaba Group (BABA), Tesla (TSLA), Bristol Myers Squibb (BMY) and Gilead Sciences (GILD).

Company Calendar

Last Earnings
7/30/2025
Today
8/09/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
MED - GENERIC DRG
Sub-Industry
Pharmaceutical Products
Current Symbol
NYSE:BHC
CIK
885590
Employees
20,700
Year Founded
N/A

Price Target and Rating

High Price Target
$10.00
Low Price Target
$8.00
Potential Upside/Downside
+56.0%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
3 Analysts

Profitability

EPS (Trailing Twelve Months)
$0.26
Trailing P/E Ratio
22.19
Forward P/E Ratio
1.31
P/E Growth
N/A
Net Income
-$46 million
Net Margins
0.99%
Pretax Margin
2.85%
Return on Equity
-852.36%
Return on Assets
5.25%

Debt

Debt-to-Equity Ratio
141.90
Current Ratio
1.31
Quick Ratio
0.98

Sales & Book Value

Annual Sales
$9.63 billion
Price / Sales
0.22
Cash Flow
$7.80 per share
Price / Cash Flow
0.74
Book Value
$0.40 per share
Price / Book
14.43

Miscellaneous

Outstanding Shares
370,130,000
Free Float
340,294,000
Market Cap
$2.14 billion
Optionable
Optionable
Beta
0.41

Social Links

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report

This page (NYSE:BHC) was last updated on 8/9/2025 by MarketBeat.com Staff
From Our Partners